The p21Cip1 and p27Kip1 CDK ‘inhibitors’ are essential activators of cyclin D‐dependent kinases in murine fibroblasts

Mangeng Cheng; Paul Olivier; J. Alan Diehl; Matthew L. Fero; Martine F. Roussel; James M. Roberts; Charles J. Sherr

doi:10.1093/emboj/18.6.1571

The p21Cip1 and p27Kip1 CDK ‘inhibitors’ are essential activators of cyclin D‐dependent kinases in murine fibroblasts

Mangeng Cheng(St. Jude Children's Research Hospital), Paul Olivier(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), J. Alan Diehl(St. Jude Children's Research Hospital), Matthew L. Fero(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Martine F. Roussel(St. Jude Children's Research Hospital), James M. Roberts(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Charles J. Sherr(St. Jude Children's Research Hospital)

The EMBO Journal

March 15, 1999

10.1093/emboj/18.6.1571

Cited by 1,142Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis